Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
JANX Janux Therapeutics, Inc.	$1.84B	$0 0.0% of portfolio	0	Q3 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$214M	$0 0.0% of portfolio	0	Q3 2024 New
KPTI Karyopharm Therapeutics Inc.	$54.3M	$0 0.0% of portfolio	0	Q3 2024 New
KZIA Kazia Therapeutics LTD	$25.7M	$0 0.0% of portfolio	0	Q3 2024 New
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	0	Q3 2024 New
KROS Keros Therapeutics, Inc.	$305M	$0 0.0% of portfolio	0	Q3 2024 New
KZR Kezar Life Sciences, Inc.	$433M	$0 0.0% of portfolio	0	Q3 2024 New
KRBP Kiromic Biopharma, Inc.	$12.7M	$0 0.0% of portfolio	0	Q3 2024 New
KOD Kodiak Sciences Inc.	$417M	$0 0.0% of portfolio	0	Q3 2024 New
KRON Kronos Bio, Inc.	$59.6M	$0 0.0% of portfolio	0	Q3 2024 New
KRYS Krystal Biotech, Inc.	$3.97B	$0 0.0% of portfolio	0	Q3 2024 New
KURA Kura Oncology, Inc.	$534M	$0 0.0% of portfolio	0	Q3 2024 New
KYMR Kymera Therapeutics, Inc.	$2.43B	$0 0.0% of portfolio	0	Q3 2024 New
LTRN Lantern Pharma Inc.	$58.5M	$0 0.0% of portfolio	0	Q3 2024 New
LRMR Larimar Therapeutics, Inc.	$155M	$0 0.0% of portfolio	0	Q3 2024 New
LVTX Lava Therapeutics Nv	$24.5M	$0 0.0% of portfolio	0	Q3 2024 New
LEGN Legend Biotech Corp	$6.18B	$0 0.0% of portfolio	0	Q3 2024 New
LEXX Lexaria Bioscience Corp.	$10.4M	$0 0.0% of portfolio	0	Q3 2024 New
LXRX Lexicon Pharmaceuticals, Inc.	$172M	$0 0.0% of portfolio	0	Q3 2024 New
LMNL Liminal Bio Sciences Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
LCTX Lineage Cell Therapeutics, Inc.	$105M	$0 0.0% of portfolio	0	Q3 2024 New
LQDA Liquidia Corp	$922M	$0 0.0% of portfolio	0	Q3 2024 New
LBPH Longboard Pharmaceuticals, Inc.	$815M	$0 0.0% of portfolio	0	Q3 2024 New
LUMO Lumos Pharma, Inc.	$36.4M	$0 0.0% of portfolio	0	Q3 2024 New
LYEL Lyell Immunopharma, Inc.	$149M	$0 0.0% of portfolio	0	Q3 2024 New
LYRA Lyra Therapeutics, Inc.	$6.05M	$0 0.0% of portfolio	0	Q3 2024 New
MGNX Macrogenics Inc	$199M	$0 0.0% of portfolio	0	Q3 2024 New
MDGL Madrigal Pharmaceuticals, Inc.	$5.61B	$0 0.0% of portfolio	1	Q4 2023 New
MAIA Maia Biotechnology, Inc.	$20.8M	$0 0.0% of portfolio	0	Q3 2024 New
MNKD Mannkind Corp	$1.55B	$0 0.0% of portfolio	74	Q1 2022 New
MRVI Maravai Lifesciences Holdings, Inc.	$739M	$0 0.0% of portfolio	0	Q3 2024 New
MRKR Marker Therapeutics, Inc.	$179M	$0 0.0% of portfolio	0	Q3 2024 New
MNOV Medicinova Inc	$93.2M	$0 0.0% of portfolio	0	Q3 2024 New
MGTX Meira G Tx Holdings PLC	$276M	$0 0.0% of portfolio	0	Q3 2024 New
MREO Mereo Biopharma Group PLC	$369M	$0 0.0% of portfolio	0	Q3 2024 New
MRSN Mersana Therapeutics, Inc.	$52.5M	$0 0.0% of portfolio	0	Q3 2024 New
MRUS Merus N.V.	$1.89B	$0 0.0% of portfolio	0	Q3 2024 New
MTCR Metacrine, Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
MIST Milestone Pharmaceuticals Inc.	$62.1M	$0 0.0% of portfolio	0	Q3 2024 New
MDXG Mimedx Group, Inc.	$999M	$0 0.0% of portfolio	0	Q3 2024 New
NERV Minerva Neurosciences, Inc.	$11.5M	$0 0.0% of portfolio	0	Q3 2024 New
INKT Mi Nk Therapeutics, Inc.	$31.4M	$0 0.0% of portfolio	0	Q3 2024 New
MIRM Mirum Pharmaceuticals, Inc.	$1.75B	$0 0.0% of portfolio	0	Q3 2024 New
MOLN Molecular Partners Ag	$173M	$0 0.0% of portfolio	0	Q3 2024 New
GLUE Monte Rosa Therapeutics, Inc.	$258M	$0 0.0% of portfolio	0	Q3 2024 New
MLTX Moon Lake Immunotherapeutics	$1.69B	$0 0.0% of portfolio	0	Q3 2024 New
MYOV Myovant Sciences Ltd.	$0	$0 0.0% of portfolio	0	Q3 2024 New
NBTX Nanobiotix S.A.	$120M	$0 0.0% of portfolio	0	Q3 2024 New
NAUT Nautilus Biotechnology, Inc.	$247M	$0 0.0% of portfolio	0	Q3 2024 New
NKTR Nektar Therapeutics	$165M	$0 0.0% of portfolio	0	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.